Posted by Michael Wonder on 24 Nov 2023
Ritlecitinib tosylate for the treatment of people with alopecia areata
24 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use of ritlecitinib tosylate in the NHS in England.
For the time being, ritlecitinib tosylate is not recommended for the treatment of people 12 years and over with severe alopecia areata.
